CAS No. 97682-44-5
| IUPAC Name | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate | |
|---|---|---|
| CAS Number | 97682-44-5 | |
| Molecular Formula |
C33H38N4O6 |
|
| Molecular Weight (MW) | 586.68 | |
| SMILES | CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7 | |
| InChIKey | UWKQSNNFCGGAFS-XIFFEERXSA-N |
Irinotecan (CPT-11) is a topoisomerase I inhibitor that exhibits cytotoxic activity against colon cancer cell lines, including LoVo and HT-29. As a semisynthetic derivative of camptothecin, irinotecan is converted into its active metabolite SN-38, which potently inhibits topoisomerase I. This inhibition stabilizes the topoisomerase I-DNA cleavage complex, preventing DNA replication and transcription and ultimately inducing DNA double-strand breaks and apoptotic cell death. [1][2]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| DMSO |
25 mg/mL
(42.61 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
25 mg/mL
(42.61 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
25 mg/mL
(42.61 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
25 mg/mL
(42.61 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
25 mg/mL
(42.61 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Irinotecan (CPT-11) Clinical Trials
- Irinotecan (CPT-11) Solubility in DMSO
- Irinotecan (CPT-11) Stock Solution
- Irinotecan (CPT-11) Storage
- Irinotecan (CPT-11) Stability
- Irinotecan (CPT-11) Molecular Weight
- Irinotecan (CPT-11) SMILES
- Irinotecan (CPT-11) Chemical Structure (2D and 3D)
- Irinotecan (CPT-11) SDS|MSDS